Clear Search sequence regions

  • child (2)
  • child mortality (3)
  • humans (1)
  • mortality (2)
  • vitamin (14)
  • Sizes of these terms reflect their relevance to your search.

    It is usually acknowledged that high-dose vitamin A supplementation (VAS) provides no sustained improvement in vitamin A status, and that the effect of VAS on mortality is more likely linked to its immunomodulating effects. Nonetheless, it is widely assumed that we can deduce something about the need for continuing or stopping VAS programs based on studies of the biochemical prevalence of vitamin A deficiency (VAD). This is no longer a tenable assumption. The justification for using VAS is to reduce child mortality, but there is now doubt that VAS has any effect on overall child mortality. What we need now are not surveys of VAD, but proper randomized trials to evaluate whether VAS has beneficial effects on overall child survival.


    Christine Stabell Benn. We Need Studies of the Mortality Effect of Vitamin A Supplementation, Not Surveys of Vitamin A Deficiency. Nutrients. 2017 Mar 15;9(3)

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 28294986

    View Full Text